Masae Yoshikawa

422 total citations
28 papers, 346 citations indexed

About

Masae Yoshikawa is a scholar working on Molecular Biology, Biochemistry and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Masae Yoshikawa has authored 28 papers receiving a total of 346 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Biochemistry and 5 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Masae Yoshikawa's work include Antioxidant Activity and Oxidative Stress (6 papers), Vitamin C and Antioxidants Research (5 papers) and Metal complexes synthesis and properties (3 papers). Masae Yoshikawa is often cited by papers focused on Antioxidant Activity and Oxidative Stress (6 papers), Vitamin C and Antioxidants Research (5 papers) and Metal complexes synthesis and properties (3 papers). Masae Yoshikawa collaborates with scholars based in Japan, United States and China. Masae Yoshikawa's co-authors include Nagahiko SAKUMA, Takeshi Hibino, Isao Kitagawa, Takao Fujinami, Takaaki Sato, Akihiko Kawaguchi, Emiko Uchida, Hiroki Yoshioka, Satoshi Yoshizumi and Wataru Fujii and has published in prestigious journals such as Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, Planta Medica and Biological and Pharmaceutical Bulletin.

In The Last Decade

Masae Yoshikawa

26 papers receiving 344 citations

Peers

Masae Yoshikawa
Masae Yoshikawa
Citations per year, relative to Masae Yoshikawa Masae Yoshikawa (= 1×) peers Amr D. Mariee

Countries citing papers authored by Masae Yoshikawa

Since Specialization
Citations

This map shows the geographic impact of Masae Yoshikawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masae Yoshikawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masae Yoshikawa more than expected).

Fields of papers citing papers by Masae Yoshikawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masae Yoshikawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masae Yoshikawa. The network helps show where Masae Yoshikawa may publish in the future.

Co-authorship network of co-authors of Masae Yoshikawa

This figure shows the co-authorship network connecting the top 25 collaborators of Masae Yoshikawa. A scholar is included among the top collaborators of Masae Yoshikawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masae Yoshikawa. Masae Yoshikawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fukaya, Shusaku, et al.. (2025). Usefulness of an Intermittently Scanned Continuous Glucose Monitoring System for Risk Management of Individuals without Diabetes in Japan. Biological and Pharmaceutical Bulletin. 48(3). 234–240.
2.
Yoshioka, Hiroki, Kenichi Ogata, Hirotaka Yamashita, et al.. (2025). Disturbance on drug efficacy of dapagliflozin, an SGLT2 inhibitor, in mice. Biomedical Research. 46(4). 137–144.
3.
Yoshioka, Hiroki, Takeshi Moriishi, Satoshi Yokota, et al.. (2023). Sasa veitchii extract alleviates nonalcoholic steatohepatitis in methionine–choline deficient diet‐induced mice by regulating peroxisome proliferator‐activated receptor alpha. Traditional & Kampo Medicine. 10(3). 259–268. 11 indexed citations
4.
Itô, Junko, et al.. (2023). Investigation of appropriate needle length considering skin thickness with the real injection posture for insulin injections in diabetic patients. Journal of Pharmaceutical Health Care and Sciences. 9(1). 19–19. 1 indexed citations
5.
Yoshioka, Hiroki, Yasuro Shinohara, Makoto Nakao, et al.. (2020). Different Renal Chronotoxicity of Bromobenzene and Its Intermediate Metabolites in Mice. Biological and Pharmaceutical Bulletin. 44(1). 150–153. 6 indexed citations
6.
Mizutani, Hideki, Yoshitaka Hayashi, Masanori Imai, et al.. (2019). Oxidative DNA Damage and Apoptosis Induced by Aclarubicin, an Anthracycline: Role of Hydrogen Peroxide and Copper. Anticancer Research. 39(7). 3443–3451. 12 indexed citations
7.
Yoshioka, Hiroki, et al.. (2019). Chronopharmacology of dapagliflozin-induced antihyperglycemic effects in C57BL/6J mice. Obesity Research & Clinical Practice. 13(5). 505–510. 6 indexed citations
8.
Mizutani, Hideki, Kenji Ikemura, Masanori Imai, et al.. (2018). Oxidative DNA Damage Induced by Pirarubicin, an Anthracycline Anticancer Agent, in the Presence of Copper(II). Anticancer Research. 38(5). 2643–2648. 11 indexed citations
9.
Yoshioka, Hiroki, et al.. (2018). Sasa veitchii extract protects against carbon tetrachloride-induced hepatic fibrosis in mice. Environmental Health and Preventive Medicine. 23(1). 49–49. 19 indexed citations
10.
Mizutani, Hideki, Kenji Ikemura, Daisuke Miyazawa, et al.. (2017). Pirarubicin, an Anthracycline Anticancer Agent, Induces Apoptosis Through Generation of Hydrogen Peroxide. Anticancer Research. 37(11). 6063–6069. 27 indexed citations
11.
SAKUMA, Nagahiko, Masae Yoshikawa, Takeshi Hibino, et al.. (2002). HDL3 Exerts a More Powerful Antiperoxidative and Protective Effect against Peroxidative Modification of LDL than HDL2 Does.. Journal of Nutritional Science and Vitaminology. 48(4). 278–282. 21 indexed citations
12.
SAKUMA, Nagahiko, Masae Yoshikawa, Takeshi Hibino, et al.. (2001). Ascorbic Acid Protects against Peroxidative Modification of Low-Density Lipoprotein, Maintaining Its Recognition by LDL Receptors.. Journal of Nutritional Science and Vitaminology. 47(1). 28–31. 9 indexed citations
13.
Yoshikawa, Masae, et al.. (1998). Strong synergistic anti-peroxidative effects of HDL3 and ascorbic acid against copper-catalyzed LDL peroxidation. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1406(3). 307–314. 3 indexed citations
15.
Yoshikawa, Masae, Nagahiko SAKUMA, Takeshi Hibino, Takaaki Sato, & Takao Fujinami. (1997). HDL3 exerts more powerful anti-oxidative, protective effects against copper-catalyzed LDL oxidation than HDL2. Clinical Biochemistry. 30(3). 221–225. 57 indexed citations
16.
Kitagawa, Isao, et al.. (1995). 生薬修治の化学的研究 VIII 地黄の成分について 2 レーマグルチンCと中国産地黄,Rehmannia glutinosa Liboschの乾燥根,より単離したグルチノシドの絶対立体構造. Chemical and Pharmaceutical Bulletin. 43(7). 1096–1100. 12 indexed citations
17.
Yoshikawa, Masae, Nagahiko SAKUMA, Takeshi Hibino, et al.. (1994). Inhibitory Effect of Ascorbic Acid on the Copper-mediated Oxidative Modification of Low-density Lipoprotein. The Journal of Japan Atherosclerosis Society. 22(2-3). 203–207. 1 indexed citations
18.
Yoshikawa, Masae, et al.. (1992). Galloyl-oxypaeoniflorin, suffruticosides A, B, C, and D, five new antioxidative glycosides, and suffruticoside E, a paeonol glycoside, from Chinese Moutan Cortex.. Chemical and Pharmaceutical Bulletin. 40(8). 2248–2250. 55 indexed citations
19.
Kitagawa, Isao, et al.. (1983). サポニンとサポゲノール XXXVII アストラガリ根,Astragalus membranaceus Bungeの根の化学成分 4 アストラガロシドVIIおよびVIII. Chemical and Pharmaceutical Bulletin. 31(2). 716–722. 1 indexed citations
20.
Kitagawa, Isao, et al.. (1983). サポニンとサポゲノール XXXV アストラガリ根,Astragalus membranaceus Bungeの根の化学成分 2 アストラガロシドI,IIおよびIV,アセチルアストラガロシドIならびにイソアストラガロシドIおよびII. Chemical and Pharmaceutical Bulletin. 31(2). 698–708. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026